Qwo — Competitive Intelligence Brief

Qwo (Qwo) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Collagenase enzyme. Area: Dermatology.

marketed Collagenase enzyme Collagen types I and III Dermatology Small molecule

Target snapshot

Qwo (Qwo) — DMR Research, PLLC. Qwo is a mixture of collagenase clostridium histolyticum enzymes that enzymatically breaks down collagen in subcutaneous tissue to reduce the appearance of cellulite.

Comparator set (5 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Qwo TARGET	Qwo	DMR Research, PLLC	marketed	Collagenase enzyme	Collagen types I and III
Collagenase Clostridium Histolyticum-Aaes	Collagenase Clostridium Histolyticum-Aaes	Luxurgery	marketed	Collagenase enzyme	Collagen types I and III
XIAFLEX	XIAFLEX	Hospital for Special Surgery, New York	marketed	Collagenase enzyme	Collagen (types I, II, III, IV, V, VI, VII)
Injectable clostridial collagenase	Injectable clostridial collagenase	Indiana Hand to Shoulder Center	marketed	Collagenase enzyme	Collagen (types I and III)
Control - Crossover to CCH	Control - Crossover to CCH	Charitable Union for the Research and Education of Peyronie's Disease	marketed	Collagenase enzyme	Collagen (types I and III)
CCH administration	CCH administration	Charitable Union for the Research and Education of Peyronie's Disease	marketed	Collagenase enzyme	Collagen I and III

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Collagenase enzyme class)

1. Charitable Union for the Research and Education of Peyronie's Disease · 2 drugs in this class
2. DMR Research, PLLC · 1 drug in this class
3. Hospital for Special Surgery, New York · 1 drug in this class
4. Indiana Hand to Shoulder Center · 1 drug in this class
5. Luxurgery · 1 drug in this class